MEDPLUSNSEMedplus Health Services Limited· RetailingHighNeutral
Announced Fri, 31 Oct, 2025 · 17:12 IST

MedPlus Q2 net profit rises 43.4% as revenue increases 6.5%

Pat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

MEDPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+7.0%Reaction day
₹762.00
prior close
₹787.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.1%+5.9% vs market
Retailing peers, median of 53sector · industry level-0.2%+7.2% vs sector

On the reaction day the stock moved 5.9 pts more than Nifty Microcap 250 and 7.2 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.2
10m
+0.9
15m
+1.1
30m
+1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+7.0+1.1+5.9-0.2+7.2
Next day
+7.0+0.3+6.7-0.8+7.7
2d
+3.0-1.4+4.4-1.5+4.5
3d
+3.4-1.0+4.4-2.2+5.6
4d
-0.5-1.4+0.9-3.2+2.7
5d
-0.3-1.6+1.4-3.0+2.7
1w
+2.6-0.8+3.4-3.6+6.2
15d
+3.0-3.6+6.6-5.4+8.4
1m
+4.6-4.0+8.6-6.1+10.7
2m
+7.5-3.9+11.4-8.1+15.6
3m
+12.9-8.4+21.3-15.3+28.2
UpDownMarket · Nifty Microcap 250Sector · Retailing peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board approved unaudited results for the quarter and half year ended September 30, 2025. Consolidated quarterly revenue was Rs 16,793.29 million, up 6.5 percent. Net profit rose 43.4 percent to Rs 555.02 million. Half-year revenue rose 5.1 percent to Rs 32,219.63 million, while profit rose 84.4 percent to Rs 978.45 million. Operating cash flow was Rs 3,133.37 million.

Likely market impact

Strong profit and cash flow growth support shareholder sentiment, but modest sales growth and Rs 11.93 billion in lease liabilities need attention.